Lifecore Biomedical Inc (LFCR)
5.87
+0.10
(+1.73%)
USD |
NASDAQ |
May 17, 16:00
5.85
-0.02
(-0.34%)
After-Hours: 20:00
Lifecore Biomedical Net Income (Quarterly): -36.13M for May 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | -35.57M |
| February 28, 2023 | -40.19M |
| November 30, 2022 | -12.45M |
| August 31, 2022 | -11.35M |
| May 31, 2022 | -55.60M |
| February 28, 2022 | -13.09M |
| November 30, 2021 | -38.44M |
| August 31, 2021 | -9.477M |
| May 31, 2021 | -2.495M |
| February 28, 2021 | -5.498M |
| November 30, 2020 | -13.30M |
| August 31, 2020 | -11.00M |
| May 31, 2020 | -15.15M |
| February 29, 2020 | -11.52M |
| November 30, 2019 | -6.74M |
| August 31, 2019 | -4.784M |
| May 31, 2019 | -0.261M |
| February 28, 2019 | 1.067M |
| November 30, 2018 | -0.584M |
| August 31, 2018 | 0.19M |
| May 31, 2018 | 6.108M |
| February 28, 2018 | 16.09M |
| November 30, 2017 | 0.487M |
| August 31, 2017 | 2.146M |
| May 31, 2017 | 2.452M |
| Date | Value |
|---|---|
| February 28, 2017 | 3.50M |
| November 30, 2016 | 1.326M |
| August 31, 2016 | 3.312M |
| May 31, 2016 | 4.729M |
| February 29, 2016 | -21.19M |
| November 30, 2015 | 1.868M |
| August 31, 2015 | 2.952M |
| May 31, 2015 | 4.196M |
| February 28, 2015 | 3.772M |
| November 30, 2014 | 3.223M |
| August 31, 2014 | 2.353M |
| May 31, 2014 | 4.542M |
| February 28, 2014 | 6.40M |
| November 30, 2013 | 3.451M |
| August 31, 2013 | 4.752M |
| May 31, 2013 | 4.519M |
| February 28, 2013 | 4.789M |
| November 30, 2012 | 8.913M |
| August 31, 2012 | 4.366M |
| May 31, 2012 | 2.779M |
| February 29, 2012 | 4.765M |
| November 30, 2011 | 3.34M |
| August 31, 2011 | 1.812M |
| May 31, 2011 | -2.737M |
| February 28, 2011 | 2.298M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-55.60M
Minimum
May 2022
-0.261M
Maximum
May 2019
-16.88M
Average
-11.52M
Median
Feb 2020
Net Income (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -12.83M |
| SELLAS Life Sciences Group Inc | -9.566M |
| ADMA Biologics Inc | 17.81M |
| Relmada Therapeutics Inc | -21.83M |
| Jaguar Health Inc | -9.226M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 31.55M |
| Total Expenses (Quarterly) | 36.96M |
| EPS Diluted (Quarterly) | -1.19 |